BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 5,100.00
+20.00 (0.39%)
Last updated: Jun 5, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 516.94 billion as of June 6, 2025. Its market cap has increased by 23.69% in one year.
Market Cap
516.94B
Enterprise Value
132.75B
Revenue
105.92B
Ranking
n/a
PE Ratio
12.24
Stock Price
5,100.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 516.94B, a decrease of -52.35%. That is a compound annual growth rate of -26.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 516.94B | 7.54% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.53T |
| Celltrion | 34.68T |
| ALTEOGEN | 19.69T |
| Yuhan | 7,778.15B |
| SK Biopharmaceuticals | 7,079.52B |
| HLB Co., Ltd. | 6,860.00B |
| PharmaResearch | 4,976.64B |
| LigaChem Biosciences | 3,893.48B |